![]() FRE 15 May 2017 | Other | €0.62 Per Share |
![]() FRE 17 May 2016 | Other | €0.55 Per Share |
![]() FRE 21 May 2015 | Other | €0.44 Per Share |
![]() FRE 16 May 2014 | Other | €1.25 Per Share |
![]() FRE 15 May 2017 | Other | €0.62 Per Share |
![]() FRE 17 May 2016 | Other | €0.55 Per Share |
![]() FRE 21 May 2015 | Other | €0.44 Per Share |
![]() FRE 16 May 2014 | Other | €1.25 Per Share |
Medical Care Facilities Industry | Healthcare Sector | Mr. Michael Sen CEO | XSTU Exchange | DE0005785604 ISIN |
Germany Country | 177,091 Employees | 23 Aug 1970 Last Dividend | - Last Split | - IPO Date |
Fresenius SE & Co. KGaA is a leading health care company specializing in providing a wide range of products and services for chronically ill patients. With its operations divided into four primary segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed, the company caters to the varied needs of patients worldwide. Fresenius Medical Care focuses on offering solutions for those suffering from chronic kidney failure, while Fresenius Kabi is dedicated to the therapy and care of critically and chronically ill patients through its range of drugs, nutrition products, and medical technologies. Fresenius Helios operates clinical and nursing care facilities, and Fresenius Vamed delivers services for hospitals and other healthcare facilities, including operational management. Established in 1912 and formerly known as Fresenius SE, the company underwent a name change in January 2011 to Fresenius SE & Co. KGaA. Headquartered in Bad Homburg vor der Höhe, Germany, Fresenius stands as a testament to innovation and dedication in the healthcare sector.